Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010;12(1):107.
doi: 10.1186/ar2927. Epub 2010 Feb 22.

Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge

Irene Em Bultink
Editorial

Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge

Irene Em Bultink. Arthritis Res Ther. 2010.

Abstract

Cardiovascular disease (CVD) has been identified as a major contributor to morbidity and mortality in patients with systemic lupus erythematosus (SLE). The etiology of premature CVD in SLE is supposed to have many factors, including traditional coronary artery disease (CAD) risk factors, antiphospholipid antibodies, and metabolic and inflammatory factors. Despite the overwhelming interest in CVD in SLE research, prospective studies evaluating risk factors for hard endpoints (that is, cardiovascular events) are relatively scarce. The article by Gustafsson and colleagues suggests that prothrombotic factors play an important role in SLE-related CVD and that the influence of traditional CAD risk factors might be limited.

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Gustafsson J, Gunnarsson I, Börjesson O, Petterson S, Möller S, Guo-Zhong F, Elvin K, Simard JF, Hansson L-O, Lundberg IE, Larsson A, Svenungsson E. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther. 2009;11:R186. doi: 10.1186/ar2878. - DOI - PMC - PubMed
    1. Toloza SM, Uribe AG, McGwin G Jr, Alarcón GS, Fessler BJ, Bastian HM, Vilá LM, Wu R, Shoenfeld Y, Roseman JM, Reveille JD. for the LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004;50:3947–3957. doi: 10.1002/art.20622. - DOI - PubMed
    1. Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus. A comparison of three ethnic groups. Arthritis Rheum. 2005;52:2774–2782. doi: 10.1002/art.21224. - DOI - PubMed
    1. Urowitz MB, Ibanez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: Prevalence and risk factors. J Rheumatol. 2007;34:70–75. - PubMed
    1. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae S-C, Isenberg D, Zoma A, Aranow C, Dooley M-A, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal J-L, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–2557. doi: 10.1002/art.21955. - DOI - PubMed